Several clinical isolates of the severe acute respiratory syndrome-associated coronavirus (SARS-CoV) have been isolated, including FFM-1 and FFM-2 from SARS patients admitted to the Clinical Centre of Frankfurt University.[@bib1] So far, no specific treatment has been identified for SARS, but attempts are being made to identify antiviral agents that could be effective in treating the SARS-CoV infection.[@bib2]

We assessed the antiviral potential of recombinant interferons α, β, and γ against two clinical isolates (FFM-1 and Hong Kong: obtained from Dr Niedrig, Robert Koch Institute, Berlin) of SARS-CoV. We used commercially available interferons (Intron A \[interferon α-2b\], Essex Pharma, Munich, Germany; Betaferon \[interferon β-1b\], Schering, Berlin; and Imukin \[interferon γ-1b\], Boehringer, Ingelheim) that have been used for their antiviral, antitumour, and immunomodulating activities. We visually scored cytopathogenic effects induced by the virus 72 h after infection in 96-well microplates on confluent layers of Vero and Caco2 cells, the latter derived from human colonic tumour, treated with interferons 24 h before and immediately after virus infection (mutiplicity of infection 0--01). The selectivity index was defined as the ratio of the concentration of the interferon that reduced cell viability to 50% (CC~50~) to the concentration of the compound needed to inhibit the cytopathic effect to 50% of control value (EC~50~). We assessed the cytotoxic effects of the drugs with an MTT cell-proliferative Kit I (Roche, Mannheim, Germany). Viral titres in supernatants collected from infected cultures 72 h after infection were measured by the 50% tissue culture infective dose (TCID~50~) calculated from cytopathogenic effects induced in monolayers incubated with varying dilutions of the supernatants. To validate the interferon effects on SARS-CoV, we included vesicular stomatitis virus (strain Indiana), replication of which is extremely sensitive to interferon action.

Interferon β was the most potent inhibitor of SARS-CoV ([table](#tbl1){ref-type="table"} ). In Vero cells, selectivity index of interferon β activity for SARS-CoV strain FFM-1 was 50-fold and 25-fold higher than that of interferon α and interferon γ, respectively. Sensitivity of the Hong Kong isolate was similar to that for the FFM-1 strain. Interferon β (EC~50~ 105 IU/mL) was more potent than interferons α or γ (EC~50s~ 6500 IU/mL and 1700 IU/mL, respectively). Vesicular stomatitis virus strain Indiana was much more sensitive to interferon treatment than SARS-CoV; interferon β had the highest antiviral activity in Vero cell cultures (EC~50~ 18 IU/mL).TableEffect of Interferons on virus-induced cytopathogenic effects of SARS-CoV and vesicular stomatitis virus**Mean (SD) EC~50~ (IU/mL)**[\*](#tbl1fn1){ref-type="table-fn"}**CC~50~ (IU/mL)Selectivity index**SARS-CoV FFM-1SARS-CoV Hong KongVSV IndianaSARS-CoV FFM-1SARS-CoV Hong KongVSV Indiana**Vero**[†](#tbl1fn2){ref-type="table-fn"}**Interferon α**4950 (890)6500 (980)638 (98)\>10000\>2\>1·5\>16Interferon β95 (17)105 (21)18·0 (3·7)\>10000\>105\>95\>556Interferon γ2500 (340)1700 (290)508 (62)\>10000\>4\>5·9\>20**Caco2**[†](#tbl1fn2){ref-type="table-fn"}Interferon α1530 (220)880 (130)3700 (420)\>10000\>6·5\>11·4\>2·7Interferon β21·0 (3·9)9·2 (2·1)1030 (150)\>10000\>476\>1087\>9·7Interferon γ\>10000\>10000\>10000\>10000NCNCNC[^1][^2][^3]

We studied the action of interferons on SARS-CoV-induced cytopathogenic effects in Vero cells when the drugs were added after infection (1 h adsorption period). Interferon β was active against FFM-1 strain (EC~50~ 560 IU/mL) but interferons α and β were not. Therefore, only interferon β can be used as an antiviral agent after infection, even though its EC~50~ value shows a six fold increase over the value obtained in pretreated cultures ([table](#tbl1){ref-type="table"}).

We assessed also the relevance of inhibition of virus replication for suppression of virus-induced cytopathogenic effects in cultures treated with interferon β 24 h before and immediately after virus infection. We infected Vero cells with FFM-1 strain at multipicity of infection 0·01 and assessed viral replication by peroxidase staining with immune serum after treatment with different concentrations of interferon ([figure](#fig1){ref-type="fig"} ). Native cells, or cells fixed with 60 parts methanol to 40 parts acetone were assessed 72 h after infections. We also quantified the genomic titre (RNA copies/mL) with real-time PCR. Interferon β showed a dose-dependent inhibition of the production of infectious virus in culture. In the absence of virus induced cytopathogenic effects, however, interferon β treatment did not completely reduce virus titre and antigen production. In cultures treated with 10 000 IU/mL, a reduction of about 5×10[@bib4]-fold was noted compared with the untreated control (1·9×10^2^ *vs* 9·7×10^6^ TCID~50~ /mL). The number of gene copies are reduced by interferon β in a dose-dependent way; however, the magnitude is around 3·3--4·5 log higher than the infectious virus titre measured in cell culture. This difference may be due to the presence of non-infectious viral RNA or the overexpression of the sequence amplified in our real-time PCR system. Similar observations have been made by Garcia and colleagues[@bib3] on the quantitative detection of Rift valley fever virus gene copies to assess the antiviral effect of drugs.FigureEffect of interferon β on replication of SARS-CoV strain: FFM-1 in Vero cells 72 h after infectionVirus detected in serum with peroxidase staining. \*Values represent mean (SD) from three experiments, each done in triplicate.

Interferons α and β share components of the same receptor and are type I interferons. Interferon γ uses a different receptor system and is a type II interferon. We noted that interferon β was by far more effective than interferon α against SARS-CoV and vesicular stomatitis virus. Although interferons α and β primarily induce the same proteins, some proteins may be induced by one better than the other. By use of oligonucleotide arrays, Der and colleagues[@bib4] identified the genes differentially regulated by interferons. They reported more than a 21-fold increase of MxA protein by interferon α, more than a 31-fold increase by interferon β, and none by interferon γ. Gene-array analysis of Caco2 cells infected with FFM-1 in our laboratory has shown a nine-fold increase of MxA gene expression in cultures 24 h after infection. This increase could be one of the reasons for amplification of interferon β effect that yields the higher antiviral potential.

Interferons α and γ, alone or in combination, are partly effective against animal coronaviruses, mouse hepatitis virus, and transmissible gastroenteritis virus; a few data on human studies report a limited response of interferon α by the intranasal route.[@bib5] We showed that interferons inhibit SARS-CoV replication in vitro. Interferon β was most potent, showing prophylactic protection and antiviral potential after infection. Interferon β could be the drug of choice, alone or in combination with other antiviral drugs,[@bib2] in the treatment of SARS.
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[^1]: VSV=vesicular stomatitis virus. NC=not calculable

[^2]: Mean (SD) of eight assays.

[^3]: Cells treated with interferons 24 h before and during virus infection.
